Literature DB >> 22933880

Pulmonary arterial hypertension: an unusual cause of portal hypertension.

Enric Reverter, Susana Seijo, Jaime Bosch.   

Abstract

Entities:  

Year:  2012        PMID： 22933880      PMCID： PMC3424479     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  38 in total

1.  Target controlled infusion of remifentanil and propofol for cesarean section in a patient with multivalvular disease and severe pulmonary hypertension.

Authors:  E Mertens; V Saldien; H Coppejans; K Bettens; M Vercauteren
Journal:  Acta Anaesthesiol Belg       Date:  2001

2.  Severe pulmonary hypertension in liver transplant candidates.

Authors:  M A Ramsay; B R Simpson; A T Nguyen; K J Ramsay; C East; G B Klintmalm
Journal:  Liver Transpl Surg       Date:  1997-09

3.  Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients.

Authors:  L A Colombato; L Spahr; J P Martinet; M P Dufresne; M Lafortune; D Fenyves; G Pomier-Layrargues
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

4.  Life-threatening variceal hemorrhage in a woman with severe pulmonary arterial hypertension.

Authors:  Bashar Almadani; Namita Sood; Martha Yearsley; William M Lee
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-06

Review 5.  Heart diseases affecting the liver and liver diseases affecting the heart.

Authors:  J E Naschitz; G Slobodin; R J Lewis; E Zuckerman; D Yeshurun
Journal:  Am Heart J       Date:  2000-07       Impact factor: 4.749

6.  Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function.

Authors:  P Van der Linden; O Le Moine; M Ghysels; M Ortinez; J Devière
Journal:  Hepatology       Date:  1996-05       Impact factor: 17.425

7.  Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.

Authors:  R Bañares; E Moitinho; B Piqueras; M Casado; J C García-Pagán; A de Diego; J Bosch
Journal:  Hepatology       Date:  1999-07       Impact factor: 17.425

8.  Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis.

Authors:  E Lotterer; A Wengert; W E Fleig
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

9.  Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study.

Authors:  A Escorsell; L Ruiz del Arbol; R Planas; A Albillos; R Bañares; P Calès; D Pateron; B Bernard; J P Vinel; J Bosch
Journal:  Hepatology       Date:  2000-09       Impact factor: 17.425

10.  Cardiac ascites: a characterization.

Authors:  B A Runyon
Journal:  J Clin Gastroenterol       Date:  1988-08       Impact factor: 3.062
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.